"Given the economic climate, everyone is trying to get in line at the trough, " says Charles Cantor , a bioterrorism expert and chief scientific officer at San Diego biotech firm Sequenom (nasdaq: SQNM - news - people ).

FORBES: Biotechs See Dollar Signs In War